Clinical trials recruiting for Autoimmune Diseases
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| California | 2 |
| Kentucky | 2 |
| Wisconsin | 2 |
| Florida | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
- Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
- Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
- Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
- Biologics And Clinical Immunology Cohort at Sinai
- Biomarkers in Autoimmune Disease of Nervous System
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- CAR-T Cells Therapy for Patients With Autoimmune Diseases
- CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
- Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
- Deciphering the Genetic Architecture of Autoimmune Diseases
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
- IMPACT - AndHealth Autoimmune Research Registry
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
- Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
- Rheumatology Diet Study
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
- Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
- The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
Related conditions
Trials recruiting for Autoimmune Diseases often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Autoimmune Diseases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.